
ABB Ltd
ABBNYOTCIndustrials● Active
$103.36
+$2.41(+2.39%)
Market Cap$187.6B
P/E Ratio—
52W High$110.2
52W Low$56.25
ABB Ltd(ABBNY)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · ABBNY · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $33.22B | $32.85B | $32.23B | $29.45B | $28.95B |
| Cost of Revenue | $19.58B | $20.58B | $21.02B | $19.74B | $19.48B |
| Gross Profit | $13.64B | $12.27B | $11.21B | $9.71B | $9.47B |
| Gross Margin %(computed) | 41.06% | 37.36% | 34.79% | 32.98% | 32.71% |
| Operating Expenses | |||||
| R&D Expenses | $1.32B | $1.47B | $1.32B | $1.17B | $1.22B |
| G&A Expenses | $6.59B | $2.15B | $2.13B | $1.88B | $1.88B |
| Total Operating Expenses | $7.59B | $7.20B | $6.34B | $6.37B | $3.75B |
| Operating Income | $6.05B | $5.07B | $4.87B | $3.34B | $5.72B |
| Operating Margin %(computed) | 18.20% | 15.44% | 15.11% | 11.33% | 19.75% |
| Interest Income | $0.20B | $0.21B | $0.17B | $0.07B | $0.05B |
| Interest Expense | $0.09B | $0.10B | $0.28B | $0.13B | $0.15B |
| Income Before Tax | $6.22B | $5.23B | $4.78B | $3.39B | $5.79B |
| Income Tax Expense | $1.57B | $1.28B | $0.93B | $0.76B | $1.06B |
| Net Income | $4.73B | $3.94B | $3.75B | $2.48B | $4.55B |
| Net Margin %(computed) | 14.25% | 11.98% | 11.62% | 8.41% | 15.71% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.59 | $2.13 | $2.02 | $1.30 | $2.27 |
| Wtd Avg Shares | 1.83B | 1.84B | 1.85B | 1.90B | 2.00B |
| EBITDA | $7.12B | $6.13B | $5.83B | $4.34B | $6.83B |
| EBITDA Margin %(computed) | 21.43% | 18.67% | 18.10% | 14.73% | 23.59% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B
深入了解ABB Ltd
关于ABB Ltd(ABBNY)损益表
ABB Ltd(ABBNY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ABBNY实现营收$33.22B,毛利润$13.64B(毛利率41.06%),净利润$4.73B(净利率14.25%)。
常见问题
ABBNY · 4 问ABB Ltd(ABBNY)2025财年营收为$33.22B,同比up1.1%。
ABBNY revenueABBNY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09